Premium
Retinol decreases β‐catenin protein levels in retinoic acid‐resistant colon cancer cell lines
Author(s) -
Dillard Alice C.,
Lane Michelle A.
Publication year - 2007
Publication title -
molecular carcinogenesis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.254
H-Index - 97
eISSN - 1098-2744
pISSN - 0899-1987
DOI - 10.1002/mc.20280
Subject(s) - biology , retinoic acid , cyclin d1 , catenin , cancer research , retinoid x receptor , wnt signaling pathway , adenomatous polyposis coli , mg132 , microbiology and biotechnology , small interfering rna , transcription factor , proteasome inhibitor , endocrinology , cell culture , signal transduction , biochemistry , transfection , cell cycle , colorectal cancer , cell , cancer , proteasome , nuclear receptor , gene , genetics
The β‐catenin signaling pathway is dysregulated in most cases of colon cancer resulting in an accumulation of nuclear β‐catenin and increased transcription of genes involved in tumor progression. This study examines the effect of retinol on β‐catenin protein levels in three all‐trans retinoic acid (ATRA)‐resistant human colon cancer cell lines: HCT‐116, WiDr, and SW620. Each cell line was treated with increasing concentrations of retinol for 24 or 48 h. Retinol reduced β‐catenin protein levels and increased ubiquitinated β‐catenin in all cell lines. Treatment with the proteasomal inhibitor MG132 blocked the retinol‐induced decrease in β‐catenin indicating retinol decreases β‐catenin by increasing proteasomal degradation. Multiple pathways direct β‐catenin to the proteasome for degradation including a p53/Siah‐1/adenomatous polyposis coli (APC), a Wnt/glycogen synthase kinase‐3β/APC, and a retinoid “X” receptor (RXR)‐mediated pathway. Due to mutations in β‐catenin (HCT‐116), APC (SW620), and p53 (WiDr), only the RXR‐mediated pathway remains functional in each cell line. To determine if RXRs facilitate β‐catenin degradation, cells were treated with the RXR pan‐antagonist, PA452, or transfected with RXRα small interfering RNA (siRNA). The RXR pan‐antagonist and RXRα siRNA reduced the ability of retinol to decrease β‐catenin protein levels. Nuclear β‐catenin induces gene transcription via interaction with T cell factor/lymphoid enhancer factor (TCF/LEF) proteins. Retinol treatment decreased the transcription of a TOPFlash reporter construct and mRNA levels of the endogenous β‐catenin target genes, cyclin D1 and c‐ myc . These results indicate that retinol may reduce colon cancer cell growth by increasing the proteasomal degradation of β‐catenin via a mechanism potentially involving RXR. © 2007 Wiley‐Liss, Inc.